MAPK8 and diabetes mellitus: The activation of MAPK signaling was found under high-glucose conditions/hyperglycemia in both in vivo and in vitro studies; the inhibition of phosphorylated ERK (p-ERK), p-JNK, and p-p38 could slow DM progression and decrease organ injury [60,61,62,63].